Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neutrophil responses to platelet-activating factor

J T O'Flaherty, C H Miller, J C Lewis

    Inflammation
    |September 1, 1981
    PubMed
    Summary

    Platelet-activating factor (PAF) strongly aggregates platelets and neutrophils, causing severe reactions in rabbits. Its acetylated form is key to these potent cellular stimulatory effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of trauma centre capacity and volume on the mortality risk of incoming new admissions.

    BMJ military health·2020
    Same author

    Mathematical model of thrombin generation and bleeding phenotype in Amish carriers of Factor IX:C deficiency vs. controls.

    Thrombosis research·2019
    Same author

    Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients.

    Haemophilia : the official journal of the World Federation of Hemophilia·2018
    Same author

    Reagent substitutions in the Centers for Disease Control and Prevention Nijmegen-Bethesda assay for factor VIII inhibitors.

    Haemophilia : the official journal of the World Federation of Hemophilia·2018
    Same author

    Effects of pre-analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels.

    Haemophilia : the official journal of the World Federation of Hemophilia·2018
    Same author

    Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review.

    Haemophilia : the official journal of the World Federation of Hemophilia·2018

    Area of Science:

    • Biochemistry
    • Immunology
    • Pharmacology

    Background:

    • Platelet-activating factor (PAF) is a potent lipid mediator.
    • The specific biological activities and toxicological effects of PAF require further elucidation.

    Purpose of the Study:

    • To synthesize and characterize 1-O-alkyl-2-O-acetyl-sn-glycerol-3-phosphorylcholine (PAF).
    • To evaluate the effects of PAF and its lyso derivative on platelet and neutrophil aggregation and degranulation.
    • To assess the in vivo toxicity of PAF in a rabbit model.

    Main Methods:

    • Chemical synthesis of PAF and its lyso derivative.
    • In vitro assays for platelet and neutrophil aggregation and degranulation.
    • In vivo administration of PAF to rabbits to monitor hematological and clinical parameters.

    Related Experiment Videos

    Main Results:

    • Synthesized PAF demonstrated potent platelet aggregation activity.
    • PAF induced significant aggregation and degranulation of rabbit and human neutrophils.
    • In vivo, PAF injection in rabbits caused neutropenia, thrombocytopenia, and anaphylactic symptoms.
    • The lyso derivative of PAF was significantly less potent or inactive in all tested assays.

    Conclusions:

    • 1-O-alkyl-2-O-acetyl-sn-glycerol-3-phosphorylcholine (PAF) is a potent stimulator of platelets and neutrophils.
    • The acetyl group is crucial for the potent biological activity of PAF.
    • The anaphylactic-like toxicity of PAF is likely mediated by its effects on platelets and neutrophils.